Head and Neck Cancer Trial, Recruiting NCT03751566 Sponsor: Masaryk Memorial Cancer Institute Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT03751566
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People receiving radiotherapy aimed at curing or reducing the chance of head and neck cancer returning after treatment
  • People with a moderate level of ability to carry out daily activities (not fully active, but not completely dependent on others for care)
  • People who are willing and able to take part in completing a diary to track side effects during the trial

Who may not be able to join:

  • People receiving radiotherapy for head and neck cancer that is aimed at managing symptoms rather than curing the disease
  • People whose ability to carry out daily activities is severely limited and who require significant assistance with self-care
  • People who are unlikely or unable to follow the requirements of the trial, such as completing the required diary or attending appointments (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +42054313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Masaryk Memorial Cancer Institute
Registry
ClinicalTrials.gov
Start date
5 October 2021
Est. completion
4 September 2023

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Management of acute toxicity of radiotherapy with acupuncture: Reducing the grade of acute toxicity in radiotherapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov